AI-generated summary
The authors studied HeLa cancer cells in the laboratory, treated with the drug Photofrin and then exposed to 630-nm pulsed laser light at several light doses. Using the XTT assay, they report that cells irradiated with the laser showed greater clonogenic activity than normal and PDT-treated cells for a short period after irradiation. They suggest that lower laser levels might have a biostimulatory effect similar to low-level laser therapy.
- Who or what was studied
- HeLa cells (human cervical cancer cell line) incubated in vitro
- Wavelengths
- 630 nm
- Limits stated in the abstract
- This is an in vitro cell study, so findings may not apply to people; the abstract reports no animal or clinical testing.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on jstage.jst.go.jp.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 630 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Laser, Low-level laser therapy, Wavelength, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.